Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma

Clinical trial NCT07371611 · RECRUITING

Trial details

NCT number: NCT07371611
Sponsor: Qunxing Li,MD
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Oral Squamous Cell Carcinoma Oral Squamous Cell Carcinoma (OSCC)

Start date: 2026-01-01
Primary completion: 2030-12-31
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.